Skip to main content

Table 7 Clinical outcomes and hospital resource use for patients with and without antibiotic pre-treatment

From: Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Outcome, n (%)

Early responders n = 332

Later responders n = 253

 

Without antibiotic pre-treatment n = 266

With antibiotic pre-treatment n = 61

Without antibiotic pre-treatment n = 184

With antibiotic pre-treatment n = 58

Antibiotic treatment modification while on initial therapy (excluding streamlining*)

38 (14.3)

7 (11.5)

66 (35.9)

20 (34.5)

Time to clinical stability, days, mean (SD) [median] based on Halm's criteria

2.6 (1.0) [2.0]

2.8 (0.9) [3.0]

9.2 (7.0) [7.0]

8.5 (5.7) [7.0]

Length of stay, days, mean (SD) [median]

10.1 (7.7) [8.0]

8.6 (4.5) [7.0]

17.0 (12.6) [13.0]

15.3 (9.9) [12.0]

Patients admitted to ICU

9 (3.4)

2 (3.3)

44 (23.9)

9 (15.5)

Time in ICU, days mean (SD) [median] (n)

6.3 (6.3) [4.0] (n = 9)

5.5 (2.1) [5.5] (n = 2)

10.8 (10.9) [8.0] (n = 44)

8.9 (4.3) [9.0] (n = 8)

Reinfection/recurrence§

9 (3.4)

2 (3.3)

10 (5.4)

5 (8.6)

Home-based care after discharge

6 (2.3)

0

9 (4.9)

2 (3.4)

Blood pressure support during hospitalization

    

 Fluid resuscitation

19 (7.1)

4 (6.6)

26 (14.1)

9 (15.5)

 Vasopressors

2 (0.8)

0

12 (6.5)

5 (8.6)

 Invasive procedures

0

1 (1.6)

3 (1.6)

0

Isolation required

24 (9.0)

3 (4.9)

17 (9.2)

7 (12.1)

Mechanical ventilation required during hospitalization

23 (8.6)

1 (1.6)

40 (21.7)

7 (12.1)

 Invasive

12 (4.5)

0

22 (12.0)

5 (8.6)

 Non-invasive

11 (4.1)

1 (1.6)

23 (12.5)

2 (3.4)

Parenteral nutrition

4 (1.5)

1 (1.6)

17 (9.2)

1 (1.7)

Duration of parenteral nutrition, days, mean (SD) [median]

4.5 (1.0) [5.0]

12.0 (-) [12.0]

8.6 (5.3) [7.0]

3.0 (-) [3.0]

Acute renal failure necessitating renal replacement therapy

1 (0.4)

0

5 (2.7)

1 (1.7)

Duration of renal failure, days, mean (SD) [median]

2.0 (-) [2.0]

-

14.3 (16.0) [9.5]

-

Septic shock during hospitalization

1 (0.4)

0

15 (8.2)

5 (8.6)

Mortality

2 (0.8)

0

1 (0.5)

3 (5.2)

  1. *De-escalation of treatment to narrower-spectrum antibiotics upon patient improvement or confirmed microbiological diagnosis.
  2. Includes duration of all hospitalizations for patients with recurrences.
  3. Does not include duration of all hospitalizations for patients with recurrences.
  4. §Refers to patients hospitalized again (due to CAP) after initial discharge.
  5. ICU = intensive care unit; SD = standard deviation.